UK markets open in 2 hours 58 minutes
  • NIKKEI 225

    28,035.95
    -126.88 (-0.45%)
     
  • HANG SENG

    17,964.24
    +666.30 (+3.85%)
     
  • CRUDE OIL

    78.73
    +1.49 (+1.93%)
     
  • GOLD FUTURES

    1,752.50
    +12.20 (+0.70%)
     
  • DOW

    33,849.46
    -497.57 (-1.45%)
     
  • BTC-GBP

    13,678.66
    +122.82 (+0.91%)
     
  • CMC Crypto 200

    387.14
    +6.85 (+1.80%)
     
  • ^IXIC

    11,049.50
    -176.86 (-1.58%)
     
  • ^FTAS

    4,098.49
    -13.82 (-0.34%)
     

ASHTEAD GROUP PLC - Transaction in Own Shares

Transaction in own shares

Ashtead Group plc (the "Company") announces that on 16th November 2022 it purchased for Treasury the following number of its ordinary shares of 10 pence each pursuant to its up to £1bn share repurchase programme, details of which were announced on 4th May 2021.

Description of shares: Ashtead Group plc - ordinary shares of 10 pence

Number of Shares repurchased: 12,000 Shares

Date of transaction: 16th November 2022

Average price paid per Share 4,945 pence

Lowest price paid per Share: 4,883 pence

Highest price paid per Share: 5,032 pence

Broker: Barclays Capital Securities Limited

Following the purchase of these shares, the remaining number of ordinary shares in issue will be 439,229,215 (excluding Treasury shares), and the company will hold 12,125,618 ordinary shares in Treasury.

The figure of 439,229,215 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases is attached to this announcement.

https://mma.prnewswire.com/media/1949139/Ashtead_Transaction_Summary_16_Nov.pdf

For further information, please contact:

Ashtead Group plc

Will Shaw, Director of Investor Relations

+44 (0)20 7726 9700